Evaluation of anti-atherosclerotic and vasculoprotective effect of long acting nifedipine in patients after PTCA

Journal of the Indian Medical Association

Volumn 99, Issue 9, 2001, Pages 519-522

  Vaidya, S ^a   Walwaikar, P P ^b   Kadhe, G ^b  

^a SIR J J GROUP OF HOSPITALS   (India)

^b JB Chem and Pharmaceuticals Ltd   (India)

Author keywords

Atherosclerosis; Long acting nifedipine; Percutaneous transluminal coronary angioplasty (PTCA)

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LONG ACTING DRUG; LOW DENSITY LIPOPROTEIN; NIFEDIPINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG EFFICACY; FEMALE; HEART PROTECTION; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035571522     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Holmes DR Jr, Vlietstra RE, Mock MB, Smith HC, Dorros G, Cowley MJ, et al - Restenosis after percutaneous transluminal coronary angioplasty (PTCA) : a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984; 53:77C-81C.
2. Thornton MA, Gruentzig AR, Hollman J, King SB 3d, Douglas JS - Coumadian and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 1984; 69:721-7.
3. Leimgruber PP, Roubin GS, Hollman J. Cotsonis GA, Meier B, Douglas JS, et al - Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1968; 73:710-7.
4. Meier B, Gruentzig AR, Goebel N, Pyle R, von Gosslar W, Schlumpf M - Assessment of stenoses in coronary angioplasty: inter-and intraobserver variability. Int J Cardiol 1983; 3:159-69.
5. Ernest SMPG - Long-term angiographic follow-up, cardiac events and survival in patients undergoing percutaneous transluminal coronary angioplasty. Br Heart J 1987; 57:220-5.
6. Waters D, Lesperance J, Francetich M, Causey D, Theroux P, Chiang YK, et al - A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990; 82: 1940-53.
7. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH - Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation 1990; 82:47-59.
8. Seitelberger R, Zwolfer W, Huber S, Schwarzacher S, Binder TM, Peschl F, et al - Nifedipine reduces the incidence of myocardial infarction and transient ischaemia in patients undergoing coronary bypass grafting. Circulation 1991; 83:460-8.
9. Lichtlen PR, Hugenholt PG, Rafflenbeul W - Retardation of angiographic progression of coronary artery disease by nifedipine: results of the international nifedipine trial of antiatherosclerotic therapy (INTACT). Lancet 1990; 335:1109-13.
10. Jukema JW, Zwinderman AH, van Boven AJ, Reiber JH, Van der Laarse A, Lie KI, et al - Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group. Arterioscler Thromb Vasc Biol 1996; 16: 425-30.
11. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE - Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol 1994; 23:352-7.
12. Pristipino G - Difference in coronary vasospastic response after recent myocardial infarction in Japanese and Caucasian patients [Abstract]. Circulation 1997; 96: 534.